Regulation of p53 in response to DNA damage
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation. Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS). Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide. In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription. Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation. This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair. Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide. Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UV-induced phosphorylation at Serine 15 increased p53 stability and protein level that associated with DNA damage [61].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [61]
In the citing paper
“Under normal conditions, cellular p53 protein levels are very low owing to strict control by its negative regulators MDM2 and MDMX, which promote p53 degradation through ubiquitination.27,28”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [28]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Notably, several recent reports have provided data consistent with a model in which Mdm2 interacts with p53 in undamaged cells and targets it for ubiquitin-mediated degradation (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997; Fuchs et al., 1998).”
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 2×
“Interaction of Mdm2 with this N-terminal region of p53 has been demonstrated to inhibit the ability of p53 to activate transcription (Momand et al., 1992; Oliner et al., 1993).”
BackgroundKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · cited 1×
“Initial clues suggesting that ATM may be involved in regulation of p53 in response to DNA damage came from observations that cell cycle checkpoint controls and up-regulation of p53 in response to IR are defective in A-T cells (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994).”
BackgroundHistone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884 · cited 1×
“Further support for this idea has been provided by the demonstration that certain histone acetyl-transferase (HAT) enzymes correspond to key transcriptional coactivators, such as CBP/p300 and PCAF (for reviews see Grunstein, 1997; Kouzarides, 1999).”
BackgroundA Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“The gene mutated in ataxia-telangiectasia patients was mapped to human chromosome 11q2223, and the gene, termed ATM, has been cloned (Gatti et al., 1988; Savitsky et al., 1995).”
BackgroundActivation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · cited 2×
“Thus, in addition to potentially playing a role in acetylating histones at p53-dependent promoters, CBP/p300 has been shown to be able to acetylate p53 at lysine-373 and lysine-382, whilst PCAF can acetylate p53 at lysine-320 (Gu and Roeder, 1997; Sakaguchi, 1998; Liu et al., 1999).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344 · cited 4×
“Elevated levels of p21 then inhibit the cyclin E/cdk2 and cyclin A/cdk2 kinases, thus preventing these kinases from promoting cell cycle progression (for review, see Ko and Prives, 1996; Levine, 1997).”
BackgroundInfluential
Research works printed but not linked: 3
- Lakin ND, Hann BC and Jackson SP. . 1999 Oncogene in press.
- Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E and Anderson CW. . 1992 Mol. Cell. Biol. 12: 5041–5049. · doi:10.1128/mcb.12.11.5041-5049.1992 · Paper page
- Maltzman W and Czyzyk L. . 1984 Mol. Cell. Biol. 4: 1689–1694. · DOI · Paper page
Cited by
Items 101–200 of 1,000
Fluctuations in p53 Signaling Allow Escape from Cell-Cycle Arrest
Reyes, J., Chen, J.-Y., Stewart-Ornstein, J., Karhohs, K. W., Mock, C. S., & Lahav, G. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.031 · Cited by 149
“Mo The tumor-suppressor protein p53 is a master transcriptional regulator of the response of human cells to DNA damage (Lakin and Jackson, 1999).”
5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell Proliferation
Zhu, W., Hileman, T., Ke, Y., Wang, P., Lu, S., Duan, W., Dai, Z., Tong, T., Villalona-Calero, M. A., Plass, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311703200 · Cited by 158
New Insight into microRNA Functions in Cancer: Oncogene–microRNA–Tumor Suppressor Gene Network
Zhou, K., Liu, M., & Cao, Y. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00046 · Cited by 155
“…et al., 2014), and disturbs p53-dependent apoptosis (Vazquez et al., 2008); meanwhile, activation of p53 often occurs in the response of DNA damage (Lakin and Jackson, 1999; Smith and Seo, 2002); activated Myc (an important oncogene) was involved in dysfunction of several important cell processes,…”
BackgroundSudo, T., Ota, Y., Kotani, S., Nakao, M., Takami, Y., Takeda, S., & Saya, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6499 · Cited by 164
Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis
Ricci, C., Pastukh, V., Leonard, J., Turrens, J., Wilson, G., Schaffer, D., & Schaffer, S. W. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00362.2007 · Cited by 142
The Herpes Simplex Virus Type 1 (HSV-1) Regulatory Protein ICP0 Interacts with and Ubiquitinates p53
Boutell, C., & Everett, R. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300776200 · Cited by 142
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression
Shimura, T., Kakuda, S., Ochiai, Y., Nakagawa, H., Kuwahara, Y., Takai, Y., Kobayashi, J., Komatsu, K., & Fukumoto, M. (2010) · Oncogene · doi:10.1038/onc.2010.238 · Cited by 154
Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts.
Yih, L., & Lee, T. (2000) · PubMed · Cited by 150
Polycyclic aromatic hydrocarbons induce both apoptotic and anti-apoptotic signals in Hepa1c1c7 cells
Solhaug, A. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh069 · Cited by 135
Programmable protein circuit design
Chen, Z., & Elowitz, M. B. (2021) · Cell · doi:10.1016/j.cell.2021.03.007 · Cited by 148
“Sensing intracellular proteins Cells encode important signals, such as DNA damage, in the concentrations and states of diverse intracellular proteins, such as p53 (Lakin and Jackson, 1999).”
BackgroundColeman, M. A., Yin, E., Peterson, L. E., Nelson, D. O., Sorensen, K. J., Tucker, J. D., & Wyrobek, A. J. (2005) · Radiation Research · doi:10.1667/rr3356.1 · Cited by 139
The p53 protein family and radiation sensitivity: Yes or no?
Cuddihy, A. R., & Bristow, R. G. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031764.81141.e4 · Cited by 153
p53 is essential for chemotherapy-induced hair loss.
Botchkarev, V. A., Komarova, E. A., Siebenhaar, F., Botchkareva, N. V., Komarov, P. G., Maurer, M., Gilchrest, B. A., & Gudkov, A. V. (2000) · PubMed · Cited by 160
Giuliano, S., Cheli, Y., Ohanna, M., Bonet, C., Beuret, L., Bille, K., Loubat, A., Hofman, V., Hofman, P., Ponzio, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2913 · Cited by 135
“org Downloaded from Phosphorylation of p53 on Ser(15) is crucial for its stabilization but also stimulates p53 transcriptional activity (23, 24).”
BackgroundMechanisms of Radiation Toxicity in Transformed and Non-Transformed Cells
Panganiban, R. A. M., Snow, A. L., & Day, R. M. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140815931 · Cited by 151
“For example, CREB (cAMP response element-binding) binding protein (CBP)/p300 and the p300-CBP-associated factor (PCAF) acetylate p53, protecting it from ubiquitination and degradation [64].”
BackgroundHockley, S. L., Arlt, V. M., Brewer, D., Giddings, I., & Phillips, D. H. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-260 · Cited by 122
“translational modification rather than an increase in steady-state p53 mRNA levels [56] and this would explain why up-regulation of this transcript was not observed on the microarrays.”
BackgroundFunctional analysis and intracellular localization of p53 modified by SUMO-1
Kwek, S. S., Derry, J. J., Tyner, A. L., Shen, Z., & Gudkov, A. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204362 · Cited by 149
“Post-translational modi®cations play important roles in regulating activation of p53 (reviewed in Lakin and Jackson, 1999).”
BackgroundIntegrating mutation data and structural analysis of the TP53 tumor-suppressor protein
Martin, A. C. R., Facchiano, A. M., Cuff, A. L., Hernandez-Boussard, T., Olivier, M., Hainaut, P., & Thornton, J. M. (2002) · Human Mutation · doi:10.1002/humu.10032 · Cited by 129
“If damage to the cell is too severe, p53 initiates apoptosis by inducing transcription of genes encoding proapoptotic factors [Lakin and Jackson, 1999; Chao et al., 2000]. p53 also enhances or represses the expression of genes involved in the adaptive response to stress, differentiation, and the…”
BackgroundChang, N.-S., Doherty, J., & Ensign, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208373200 · Cited by 129
Suzuki, K., Kodama, S., & Watanabe, M. (2001) · PubMed · Cited by 138
Sengupta, S., & Wasylyk, B. (2001) · Genes & Development · doi:10.1101/gad.202201 · Cited by 125
Tu, Y., Chen, C., Pan, J., Xu, J., Zhou, Z., & Wang, C. (2012) · Europe PMC (PubMed Central) · Cited by 164
A mouse model of human oral-esophageal cancer
Opitz, O. G., Harada, H., Suliman, Y., Rhoades, B., Sharpless, N. E., Kent, R., Kopelovich, L., Nakagawa, H., & Rustgi, A. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15324 · Cited by 137
“Additionally, p53 mutations are frequently found in the majority of oral and esophageal squamous cell cancers (11, 12), and their biological consequences are several, including promoting cell cycle progression, augmenting genomic instability, and decreasing growth arrest in response to genotoxic stress (13, 14).”
BackgroundWerner, H. (2011) · Oncogene · doi:10.1038/onc.2011.447 · Cited by 134
Heterochromatin silencing of p53 target genes by a small viral protein
Soria, C. T., Estermann, F. E., Espantman, K. C., & O’Shea, C. C. (2010) · Nature · doi:10.1038/nature09307 · Cited by 147
Rajavel, T., Packiyaraj, P., Suryanarayanan, V., Singh, S. K., Kandasamy, R., & Devi, K. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-20311-6 · Cited by 141
Golli‐Bennour, E. E., Kouidhi, B., Bouslimi, A., Abid‐Essefi, S., Hassen, W., & Bacha, H. (2010) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20310 · Cited by 124
“This leads to the activation of proteins involved in either cell cycle arrest and/or apoptosis [46,47].”
BackgroundPARP-1 modifies the effectiveness of p53-mediated DNA damage response
Valenzuela, M. T., Guerrero, R., Núñez, M. I., de Almodóvar, J. M. R., Sarker, M., de MURCIA, G., & Oliver, F. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205169 · Cited by 139
“Several of these responses are mediated by the stabilization and activation of the tumour-suppressor protein p53 and failure of this activation leads to genetic instability and a predisposition to cancer (Lakin and Jackson, 1999).”
BackgroundInfluentialEleawa, S. M., Alkhateeb, M. A., Al-Hashem, F. H., Bin‐Jaliah, I., Sakr, H. F., El-Refaey, H., El-Karib, A. O., Alessa, R., Haidara, M. A., Shatoor, A. S., et al. (2014) · Journal of Reproduction and Development · doi:10.1262/jrd.2013-097 · Cited by 131
“Induction of p53 is associated with a rapid increase in its levels and with an increased ability to bind DNA and mediate transcriptional activation [37].”
BackgroundOgi, T., Walker, S., Stiff, T., Hobson, E., Limsirichaikul, S., Carpenter, G., Prescott, K., Suri, M., Byrd, P. J., Matsuse, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002945 · Cited by 117
“Samples were incubated with primary antibodies for c-H2AX (Millipore, Billerica) or 53BP1 (Bethyl, Montgomery).”
BackgroundInfluentialLead-induced apoptosis in PC 12 cells: Involvement of p53, Bcl-2 family and caspase-3
Xu, J., Ji, L., & Xu, L. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.06.643 · Cited by 124
Zhao, T., & Schranz, M. E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801757116 · Cited by 120
“Interestingly, TRRAP also links to the DNA repair pathway (45, 47).”
BackgroundWalyEldeen, A. A., Sabet, S., El-Shorbagy, H. M., Abdelhamid, I. A., & Ibrahim, S. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110297 · Cited by 124
Identification of BARD1 as Mediator between Proapoptotic Stress and p53-Dependent Apoptosis
Irminger‐Finger, I., Leung, W., Li, J., Dubois‐Dauphin, M., Harb, J., Féki, A., Jefford, C. E., Soriano, J. V., Jaconi, M. E., Montesano, R., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00406-3 · Cited by 122
“It rather appears that BARD1 exerts its action on p53 at a posttranslational level, consistent TUNEL-positive cells), as compared to control cells or cells transfected with an irrelevant ribozyme (Figures 5A with the concept of posttranslational regulation of p53 levels during apoptosis (Lakin and Jackson, 1999).”
BackgroundA Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations
Cohn, R. L., Thakar, K., Lowe, A., Ladha, F. A., Pettinato, A. M., Romano, R., Meredith, E. K., Chen, Y.-S., Atamanuk, K., Huey, B. D., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.015 · Cited by 121
“To gain insights into molecular linkages between thickfilament HCM mutations and p53 activation, we started by measuring known regulators of p53, including DNA damage (Lakin and Jackson, 1999) and oxidative stress (Hwang et al.”
BackgroundSchneider‐Stock, R., Diab-Assef, M., Rohrbeck, A., Foltzer‐Jourdainne, C., Boltze, C., Hartig, R., Schönfeld, P., Roessner, A., & Gali‐Muhtasib, H. U. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074195 · Cited by 121
“p53 has been shown to play a critical role in growth arrest and apoptosis in response to DNA damage by chemotherapeutic agents (Lakin and Jackson, 1999).”
BackgroundResultInfluentialRetractedOncogene-induced senescence: From biology to therapy
Zhu, H., Blake, S., Kusuma, F. K., Pearson, R. B., Kang, J., & Chan, K. T. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111229 · Cited by 116
The cellular response to DNA damage: A focus on MDC1 and its interacting proteins
Coster, G., & Goldberg, M. (2010) · Nucleus · doi:10.4161/nucl.1.2.11176 · Cited by 122
Piecing Together the p53 Puzzle
Carr, A. M. (2000) · Science · doi:10.1126/science.287.5459.1765 · Cited by 113
Biological functions of the ING family tumor suppressors
Campos, E. I., Chin, M. Y., Kuo, W., & Li, G. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4199-4 · Cited by 133
Identification of radiation-specific responses from gene expression profile
Park, W.-Y., Hwang, C.-I., Im, C.-N., Kang, M.-J., Woo, J.-H., Kim, J.-H., Kim, Y. S., Kim, J.-H., Kim, H., Kim, K.-A., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205977 · Cited by 113
“High energy ionizing radiation (IR) can induce direct and/or indirect damage to DNA, which are followed by a variety of cellular responses like cell-cycle arrest, transformation, and cell death (Lakin and Jackson, 1999; Gong and Almasan, 2000; Backlund et al., 2001).”
Backgroundp53 and miR-34a Feedback Promotes Lung Epithelial Injury and Pulmonary Fibrosis
Shetty, S. K., Tiwari, N., Marudamuthu, A. S., Puthusseri, B., Bhandary, Y. P., Fu, J., Levin, J. L., Idell, S., & Shetty, S. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.020 · Cited by 114
The death substrate Gas2 binds m‐calpain and increases susceptibility to p53‐dependent apoptosis
Benetti, R., Sal, G. D., Monte, M., Paroni, G., Brancolini, C., & Schneider, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2702 · Cited by 129
Offer, H., Erez, N., Zurer, I., Tang, X., Milyavsky, M., Goldfinger, N., & Rotter, V. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.1025 · Cited by 106
“damage, are critical for eliciting its biological activities (38, 49 ).”
ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka, H., Bonnefin, P., Vieyra, D. S., Feng, X., Hara, Y., Miura, Y., Joh, T., Nakabayashi, H., Vaziri, H., Harris, C. C., et al. (2003) · PubMed · Cited by 145
Chen, J., & Sadowski, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407069102 · Cited by 111
Lam, M., Carmichael, A. R., & Griffiths, H. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040152 · Cited by 123
“In response to stress signals, post-translational modifications of p53 such as phosphorylation, drive its nuclear translocation and subsequent target gene transcription [6,7].”
BackgroundWhen one is better than two: RNA with dual functions
Ulveling, D., Francastel, C., & Hubé, F. (2010) · Biochimie · doi:10.1016/j.biochi.2010.11.004 · Cited by 118
“In normal conditions, p53 protein is persistently degraded by the proteasome (for review see [56; 59; 60; 97-99]).”
BackgroundChandler, D. S., Singh, R. K., Caldwell, L. C., Bitler, J. L., & Lozano, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4271 · Cited by 105
“This dichotomous response to different damaging agents mirrors what is reported for the differential specific phosphorylation of p53 that occurs in response to UV but not g irradiation (27).”
BackgroundAssociation of human papilloma virus with pterygia and ocular-surface squamous neoplasia
Girolamo, N. D. (2011) · Eye · doi:10.1038/eye.2011.312 · Cited by 118
Mechanisms of microcystin-LR-induced cytoskeletal disruption in animal cells
Zhou, M., Tu, W.-W., & Xu, J. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.05.005 · Cited by 113
“In response to multiple cellular stresses, including DNA damage, hypoxia, and nucleotide deprivation, this protein is activated through increased transcription and phosphorylation, leading to DNA repair, apoptosis and tumor suppression (Fridman and Lowe, 2003; Lakin and Jackson, 1999).”
Stewart, G. S., Last, J. I. K., Stankovic, T., Haites, N., Kidd, A. M. J., Byrd, P. J., & Taylor, A. M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103160200 · Cited by 106
SUMOylation of hnRNP‐K is required for p53‐mediated cell‐cycle arrest in response to DNA damage
Lee, S. W., Lee, M. H., Park, J. H., Kang, S. H., Yoo, H. M., Ka, S. H., Oh, Y. M., Jeon, Y. J., & Chung, C. H. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.293 · Cited by 121
“The p53 tumour suppressor plays a pivotal role in maintenance of genome integrity under cellular stresses, such as DNA damage (Lane, 1992; Lakin and Jackson, 1999; Kruse and Gu, 2009; Levine and Oren, 2009).”
AHR- and DNA-Damage-Mediated Gene Expression Responses Induced by Benzo(a)pyrene in Human Cell Lines
Hockley, S. L., Arlt, V. M., Brewer, D. S., Poele, R. T., Workman, P., Giddings, I., & Phillips, D. H. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700252n · Cited by 106
Menon, V., & Povirk, L. F. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_17 · Cited by 121
“In addition to the above regulatory role of ATM via Chk2 and MDM2, ATM directly phosphorylates serine 15 on p53 following exposure to ionizing radiation [36].”
BackgroundUddin, M. B., Roy, K. R., Hosain, S. B., Khiste, S., Hill, R. A., Jois, S. D. S., Zhao, Y., Tackett, A. J., & Liu, Y. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.014 · Cited by 105
“In cancer cells, wt p53 can be activated by stress conditions, including oncogenic activation (oncogenic stress) and DNA damage [16].”
Noonan, F. P., Otsuka, T., Bang, S., Anver, M. R., & Merlino, G. T. (2000) · PubMed · Cited by 113
Telomere dysfunction in genome instability syndromes
Callén, E., & Surrallés, J. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.06.003 · Cited by 120
“ATM responds rapidly to DSBs by phosphorylating a subset of proteins involved in different signaling pathways [109]: ATM phosphorylates p53, a key player at the G1/S cell cycle checkpoint; ChK2 kinase, with a role at G2/M checkpoint; Mdm2 protein; Brca1, which is involved in the S-phase and G2/M cell cycle checkpoints…”
Liu, G., & Chen, X. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1398-1413.2006 · Cited by 104
“Following stresses, several serine residues at both the amino terminus and the carboxyl terminus of p53 are phosphorylated (2, 31, 42).”
BackgroundJiang, C., Hu, H., Malewicz, B., Wang, Z., & Lü, J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.877.3.7 · Cited by 104
Hu, H., Jiang, C., Schuster, T. F., Li, G.-X., Daniel, P. T., & Lü, J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0063 · Cited by 104
“invariably trigger p53 activation (25), we hypothesize that the status of p53 and/or its downstream transcriptional target Bax, which is crucial for regulating mitochondrial integrity and caspase-9 pathway, may be key determinants”
BackgroundRamachandran, S., Haddad, D., Li, C., Le, M. N., Ling, A. K., So, C. C., Nepal, R. M., Gommerman, J. L., Yu, K., Ketela, T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.041 · Cited by 112
“Phosphorylation of Kap1Ser824 and p53-Ser15 is mediated by ATM, ATR, and DNAPK (Lakin and Jackson, 1999; White et al., 2006), while H2AX is phosphorylated primarily by ATM, but also by DNAPK in response to ionizing radiation-induced DSBs (Stiff et al.”
BackgroundMolecular Mechanisms of Chemotherapy-Induced Hair Loss
Botchkarev, V. A. (2003) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2003.12175.x · Cited by 100
“p53 Is essential for chemotherapy-induced hair loss in mice p53 is a transcription factor and tumor suppressor protein that plays a critical role in mediating apoptotic cell death induced by chemotherapeutic agents”
BackgroundP21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation
Soria, G., Podhajcer, O. L., Prives, C. L., & Gottifredi, V. (2005) · Oncogene · doi:10.1038/sj.onc.1209315 · Cited by 109
“Genotoxic agents used include Dauno, 0.22 mM (Oncogene Research Products) (Gewirtz, 1999); ActD, 5 nM (Calbiochem) (Sobell, 1985); HU, 1.5 mM (SIGMA) (Timson, 1975); APH, 5mg/ml (Calbiochem) (Ikegami et al., 1978); DFX 250 mM (SIGMA)(Ashcroft et al., 2000); methyl methanesulfonate, 0.02% (SIGMA) (Lakin and Jackson, 19…”
InfluentialWilliams, S. A., & McConkey, D. J. (2003) · PubMed · Cited by 113
Improving cancer therapy by non-genotoxic activation of p53
Laín, S., & Lane, D. P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00063-7 · Cited by 106
“Important findings on the induction of p53 and Mdm2 posttranslational modifications have been summarised and discussed extensively [50–55].”
BackgroundPreserving genome integrity and function: the DNA damage response and histone modifications
Kim, J. J., Lee, S. Y., & Miller, K. M. (2019) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2019.1620676 · Cited by 104
“…et al. 2015). p53 is a critical DDR regulator that controls checkpoint activation, cell cycle arrest, and apoptosis in response to DNA damage (Lakin and Jackson 1999; Reinhardt and Schumacher 2012). p53 methylation is well-studied and provides a primary example of functional lysine…”
BackgroundParaquat-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells: Involvement of p53 and Mitochondria
Yang, W., & Tiffany‐Castiglioni, E. (2008) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390701738467 · Cited by 100
“In general, various cellular stresses increase and activate p53 in the cytoplasm and p53 subsequently upregulates its target gene Bax, which promotes the release of cytochrome c into the cytoplasm from mitochondria ( Li & Ho, 1998 ; Lakin & Jackson, 1999 ; Roy et al, 2004 ; Solhaug et al, 2004 ; Xu et al, 2006 ).”
BackgroundMai, W., Yan, J.-L., Wang, L., Zheng, Y., Xin, Y., & Wang, W.-N. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.07.025 · Cited by 103
Acquired Radioresistance of Cancer and the AKT/GSK3β/cyclin D1 Overexpression Cycle
SHIMURA, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.11098 · Cited by 93
Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation
Qiao, D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.6.957 · Cited by 93
Zhang, C., Jia, X., Bao, J., Chen, S., Wang, K., Zhang, Y., Li, P., Wan, J., Su, H., Wang, Y., et al. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1036-x · Cited by 98
“We next tested whether the tumor suppressors PTEN and p53 and their potential downstream target STAT3 [11, 12, 25] were involved in PP7-induced apoptosis in HepG2 cells.”
BackgroundInfluentialChk2 regulates irradiation-induced, p53-mediated apoptosis in Drosophila
Peters, M., DeLuca, C., Hirao, A., Stambolic, V., Potter, J., Zhou, L., Liepa, J., Snow, B., Arya, S., Wong, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172382899 · Cited by 94
Ghaneh, P., Greenhalf, W., Humphreys, M. J., Wilson, D., Zumstein, L. A., Lemoine, N. R., & Neoptolemos, J. P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301394 · Cited by 100
The Notch Regulator MAML1 Interacts with p53 and Functions as a Coactivator
Zhao, Y., Katzman, R. B., Delmolino, L. M., Bhat, I., Zhang, Y., Gurumurthy, C. B., Germaniuk-Kurowska, A., Reddi, H. V., Solomon, A., Zeng, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608974200 · Cited by 98
p53-dependent SIRT6 expression protects Aβ42-induced DNA damage
Jung, E. S., Choi, H., Song, H., Hwang, Y. J., Kim, A., Ryu, H., & Mook-Jung, I. (2016) · Scientific Reports · doi:10.1038/srep25628 · Cited by 89
Thoudam, T., Jeon, J.-H., Ha, C.-M., & Lee, I.-K. (2016) · Mediators of Inflammation · doi:10.1155/2016/1851420 · Cited by 87
“It is a transcription factor that regulates expression of DNA repair proteins and initiates the production of apoptotic signals when it detects damaged and irreparable DNA [190, 191].”
BackgroundInfluentialDNA Damage-induced Inhibition of Securin Expression Is Mediated by p53
Zhou, Y., Mehta, K. R., Choi, A., Scolavino, S., & Zhang, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203793200 · Cited by 98
Tang, C., & Grimm, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310821200 · Cited by 93
Pamment, J., Ramsay, E., Kelleher, M., Dornan, D., & Ball, K. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205981 · Cited by 102
“This distinguishes IRF-1 from p53 whose activation in damaged cells is controlled by post-translational events (Lakin and Jackson, 1999).”
BackgroundEarly Single Cell Bifurcation of Pro- and Antiapoptotic States during Oxidative Stress
Nair, V. D., Yuen, T., Olanow, C. W., & Sealfon, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312135200 · Cited by 99
Swamy, M. V., Herzog, C. R., & Rao, C. V. (2003) · PubMed · Cited by 89
Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation
Santoro, R., Marani, M., Blandino, G., Muti, P. C., & Strano, S. (2011) · Oncogene · doi:10.1038/onc.2011.469 · Cited by 91
“This occurs at a specific p53 residue (Ser-15) (Kim and Yoo, 2010) that has been shown to have a critical role in orchestrating p53-reponse upon DNA-damaging agents (Lakin and Jackson, 1999; Helton and Chen, 2007).”
BackgroundZhong, X., Wang, X., Zhou, T., Jin, Y., Tan, S., Chen, J., Geng, X., Li, N., Shi, H., Zeng, Q., et al. (2017) · Marine Biotechnology · doi:10.1007/s10126-017-9757-5 · Cited by 97
“P53 activation was reported to occur in response to hypoxia and DNA damage, which will lead to cell cycle arrest, DNA repair, or apoptosis (Lakin and Jackson 1999).”
BackgroundMoulder, D. E., Hatoum, D., Tay, E., Lin, Y., & McGowan, E. M. (2018) · Cancers · doi:10.3390/cancers10060189 · Cited by 83
“One of the early identified major functions of p53 is to prevent accumulation of damaged DNA to potentiate genomic stability, thus inhibiting tumorigenesis [65].”
BackgroundA role for p53 in the frequency and mechanism of mutation
Morris, S. M. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(01)00075-8 · Cited by 96
Waring, J. F., Gum, R. J., Morfitt, D. C., Jolly, R. A., Ciurlionis, R., Heindel, M. A., Gallenberg, L. A., Buratto, B., & Ulrich, R. G. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00477-8 · Cited by 86
Local, A., Zhang, H., Benbatoul, K. D., Folger, P., Sheng, X., Tsai, C., Howell, S. B., & Rice, W. G. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1209 · Cited by 90
“TP53 is phosphorylated at Ser15 and Ser20 in response to DNA damage, which reduces MDM2 binding and proteasomal degradation of p53 (20).”
BackgroundBARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase
Féki, A., Jefford, C. E., Berardi, P., Wu, J., Cartier, L., Krause, K., & Irminger‐Finger, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208491 · Cited by 95
“To further elucidate the mechanism by which BARD1 induces apoptosis, we investigated its possible function in the regulation of p53 phosphorylation required for apoptosis (Lakin and Jackson, 1999).”
BackgroundSchwartz, E. I., Intine, R. V. A., & Maraia, R. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9580-9591.2004 · Cited by 85
“The DNA-damaging agent methyl methanesulfonate (MMS) was used as a positive control for apoptosis (31), and solvent alone was used as a negative control.”
MethodPulvers, J. N., & Huttner, W. Β. (2009) · Development · doi:10.1242/dev.033498 · Cited by 95
“Brca1 ablation in VZ progenitors of the dorsal telencephalon results in nuclear translocation of p53 Increased apoptosis caused by Brca1 removal is known to involve the p53 (Trp53) pathway (Lakin and Jackson, 1999; Xu et al., 2001; Fridman and Lowe, 2003).”
BackgroundZhou, B., Liu, X., Mo, X., Xue, L., Darwish, D., Qiu, W., Shih, J., Hwu, E. B., Luh, F., & Yen, Y. (2003) · PubMed · Cited by 94
Saini, S., & Gurung, P. (2024) · Immunological Reviews · doi:10.1111/imr.13409 · Cited by 101
Choubey, D., & Panchanathan, R. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.002 · Cited by 89
Nitric oxide-induced apoptosis in tumor cells
Umansky, V., & Schirrmacher, V. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)82004-2 · Cited by 88
The nuclear receptor RXRA controls cellular senescence by regulating calcium signaling
Ma, X., Warnier, M., Raynard, C., Ferrand, M., Kirsh, O., Defossez, P., Martin, N., & Bernard, D. (2018) · Aging Cell · doi:10.1111/acel.12831 · Cited by 87
Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage
Grishko, V., Pastukh, V., Solodushko, V., Gillespie, M., Azuma, J., & Schaffer, S. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00408.2003 · Cited by 83
“The link between DNA damage and p53 activation has been the focus of numerous studies (19, 36).”
Shang, Y. L., Bodero, A. J., & Chen, P.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210749200 · Cited by 83
The Circadian Clock Controls Sunburn Apoptosis and Erythema in Mouse Skin
Gaddameedhi, S., Selby, C. P., Kemp, M. G., Ye, R., & Sancar, A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.508 · Cited by 86
“This phosphorylation event stabilizes p53 by disrupting its interactions with Mdm2 (Lakin and Jackson, 1999; Shieh et al., 1997).”
BackgroundTranscriptional activation of p53 by Pitx1
Liu, D., & Lobie, P. E. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402209 · Cited by 93
“Regulation of p53 is known to be primarily controlled post-translationally by subcellular localization, phosphorylation, acetylation and degradation.(15) Specifically, following genotoxic stress, p53 is activated and stabilized by the DNA-damage kinases, such as ataxia telangiectasia mutated kinase (ATM), ataxia telan…”
Metadata
- Authors
- Lakin, N. D., & Jackson, S. P.
- Affiliations
- University of Cambridge (GB)
- ORCID
- Jackson, Stephen P
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7644-7655
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2007935491
- Cited by
- 987
- References
- 128
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 30 · 2023: 54 · 2022: 57 · 2021: 46 · 2020: 46 · 2019: 33 · 2018: 40 · 2017: 43 · 2016: 34 · 2015: 33 · 2014: 28 · 2013: 23 · 2012: 28
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, DNA damage response, p53 activation, post-translational modification, phosphorylation, dephosphorylation, acetylation, ionizing radiation, ultraviolet radiation, methyl methanesulfonate, cell cycle arrest, apoptosis, DNA repair, transcriptional activation, hypoxia
- MeSH terms
- Adenosine Triphosphatases, Animals, DNA Damage, DNA Helicases, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Saccharomyces cerevisiae Proteins, Proto-Oncogene Proteins c-mdm2, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.